Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept vs Adalimumab in Early Rheumatoid Arthritis
NCT02557100Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2015
- Primary completion
- Mar 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 3
01
Overview
A Phase 4 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Nov 2015; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02557100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02557100.